Page results
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
Dental extractions: post-operative instructions patient information page.
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
The bites, stings, and animal-related injury service at the Hospital for Tropical Diseases offers high-quality, specialised treatment, care, and expert advice to adult patients who have experienced animal or plant-related injuries.
-
How we use your information at UCLH: what you need to know
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
